Pegaptanib Sodium

Known as: Pegaptanib Octasodium 
The sodium salt form of pegaptanib, a 28-mer RNA aptamer covalently linked to two branched 20-kD polyethylene glycol (PEG) chains, with anti… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2017
0102020052017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
PURPOSE To confirm the safety and compare the efficacy of intravitreal pegaptanib sodium 0.3 mg versus sham injections in… (More)
Is this relevant?
2010
2010
PURPOSE To assess the efficacy and safety of intravitreous pegaptanib sodium (Macugen; EyeTech Pharmaceuticals/Pfizer Inc, New… (More)
Is this relevant?
2009
2009
BACKGROUND To compare the efficacy of intravitreal pegaptanib (IVP) with panretinal laser photocoagulation (PRP) in the treatment… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2009
2009
OBJECTIVES To assess the safety and efficacy of intravitreous pegaptanib sodium for the treatment of macular edema following… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
PURPOSE To report the functional and anatomical outcomes resulting from the use of intravitreal pegaptanib sodium (Macugen) in… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2007
2007
The purpose was to report a case of elevated intraocular vascular endothelial growth factor (VEGF) levels in a 2-year-old boy… (More)
  • figure 1
Is this relevant?
2007
2007
PURPOSE To evaluate the local tolerance, systemic toxicity, and toxicokinetics in dogs and rabbits of pegaptanib sodium, an… (More)
Is this relevant?
2006
2006
PURPOSE To report two cases of a retinal pigment epithelial tear after intravitreal injection of pegaptanib sodium. To our… (More)
Is this relevant?
2006
2006
OBJECTIVE To evaluate the safety of pegaptanib sodium injection, a specific vascular endothelial growth factor (VEGF) antagonist… (More)
Is this relevant?
2005
2005
In December 2004, pegaptanib sodium (Macugen; Eyetech/Pfizer), which targets vascular endothelial growth factor, was approved by… (More)
  • figure 1
Is this relevant?